Skip to main content
×
×
Home

Changing the obesogenic environment to improve cardiometabolic health in residential patients with a severe mental illness: cluster randomised controlled trial

  • Anne Looijmans (a1), Annemarie P. M. Stiekema (a2), Richard Bruggeman (a3), Lisette van der Meer (a4) (a2), Ronald P. Stolk (a5), Robert A. Schoevers (a6), Frederike Jörg (a4) (a7) and Eva Corpeleijn (a8)...
Abstract
Background

For patients with severe mental illness (SMI) in residential facilities, adopting a healthy lifestyle is hampered by the obesity promoting (obesogenic) environment.

Aims

To determine the effectiveness of a 12-month lifestyle intervention addressing the obesogenic environment with respect to diet and physical activity to improve waist circumference and cardiometabolic risk factors v. care as usual (Dutch Trial Registry: NTR2720).

Method

In a multisite cluster randomised controlled pragmatic trial, 29 care teams were randomised into 15 intervention (365 patients) and 14 control teams (371 patients). Intervention staff were trained to improve the obesogenic environment.

Results

Waist circumference decreased 1.51 cm (95% CI −2.99 to −0.04) in the intervention v. control group after 3 months and metabolic syndrome z-score decreased 0.22 s.d. (95% CI −0.38 to −0.06). After 12 months, the decrease in waist circumference was no longer statistically significantly different (–1.28 cm, 95% CI −2.79 to 0.23, P = 0.097).

Conclusions

Targeting the obesogenic environment of residential patients with SMI has the potential to facilitate reduction of abdominal adiposity and cardiometabolic risk, but maintaining initial reductions over the longer term remains challenging.

Copyright
Corresponding author
Anne Looijmans, MSc, University Medical Center Groningen Department of Epidemiology (FA40), PO Box 30.001, 9700 RB Groningen, The Netherlands. Email: A.Looijmans@umcg.nl
Footnotes
Hide All

This work was presented, in part, at the 25th European Congress of Psychiatry, Florence, 1–4 April 2017.

∗∗

These authors contributed equally to the work as senior authors.

Declaration of Interest

None.

Footnotes
References
Hide All
1 Laursen, TM, Wahlbeck, K, Hällgren, J, Westman, J, Ösby, U, Alinaghizadeh, H et al. Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the nordic countries. PLoS One 2013; 8: 17.
2 Zimmet, P, Magliano, D, Matsuzawa, Y, Alberti, G, Shaw, J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005; 12: 295300.
3 Hert, M, Correll, CU, Bobes, J, Cetkovich-Bakmas, M, Cohen, D, Asai, I, et al. Physical illness in patients with severe mental disorders. I. prevalence, impact of medications and disparities in health care. World Psychiatry 2011; 10: 5277.
4 McEvoy, JP, Meyer, JM, Goff, DC, Nasrallah, HA, Davis, SM, Sullivan, L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the clinical antipsychotic trials of intervention effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80: 1932.
5 McGinty, EE, Baller, J, Azrin, ST, Juliano-Bult, D, Daumit, GL. Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull 2016; 42: 96124.
6 Bruins, J, Jörg, F, Bruggeman, R, Slooff, C, Corpeleijn, E, Pijnenborg, M. The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PloS One 2014; 9: e112276.
7 Cabassa, L, Ezell, J, Lewis-Fernández, R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatr Serv 2010; 61: 774–82.
8 Daumit, GL, Dickerson, FB, Wang, N, Dalcin, A, Jerome, GJ, Anderson, CAM, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med 2013; 368: 1594–602.
9 Brar, JS, Ganguli, R, Pandina, G, Turkoz, I, Berry, S, Mahmoud, R. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005; 66: 205–12.
10 Alvarez-Jimenez, M, Gonzalez-Blanch, C, Vazquez-Barquero, JL, Pérez-Iglesias, R, Martínez-García, O, Pérez-Pardal, T, et al. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: a randomized controlled trial. J Clin Psychiatry 2006; 67: 1253–60.
11 Wu, R, Zhao, J, Jin, H, Shao, P, Fang, MS, Guo, XF, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial. JAMA 2008; 299: 185–93.
12 Hassapidou, M, Papadimitriou, K, Athanasiadou, N, Tokmakidou, V, Pagkalos, I, Vlahavas, G, et al. Changes in body weight, body composition and cardiovascular risk factors after long-term nutritional intervention in patients with severe mental illness: an observational study. BMC Psychiatry 2011; 11: 31–8.
13 Swinburn, B, Egger, G, Raza, F. Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med 1999; 29: 563–70.
14 Faulkner, G, Cohn, TA. Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Can J Psychiatry 2006; 51: 502–11.
15 Cohn, T, Grant, S, Faulkner, GE. Schizophrenia and obesity: addressing obesogenic environments in mental health settings. Schizophr Res 2010; 121: 277–8.
16 Melamed, Y, Stein-Reisner, O, Gelkopf, M, Levi, G, Sivan, T, Ilievici, G, et al. Multi-modal weight control intervention for people with persistent mental disorders. Psychiatr Rehabil J 2008; 31: 194200.
17 Sbrocco, T, Nedegaard, RC, Stone, JM, Lewis, EL. Behavioral choice treatment promotes continuing weight loss: preliminary results of a cognitive-behavioral decision-based treatment for obesity. J Consult Clin Psychol 1999; 67: 260.
18 Looijmans, A, Jörg, F, Schoevers, RA, Bruggeman, R, Stolk, RP, Corpeleijn, E. Changing the obesogenic environment of severe mentally ill residential patients: ELIPS, a cluster randomised study design. BMC Psychiatry 2014; 14: 293.
19 Treweek, S, Zwarenstein, M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 2009; 10: 9.
20 Bruins, J, Pijnenborg, MG, Bartels-Velthuis, AA, Visser, E, van den Heuvel, ER, Bruggeman, R, et al. Cannabis use in people with severe mental illness: the association with physical and mental health – a cohort study. A pharmacotherapy monitoring and outcome survey study. J Psychopharmacol 2016; 30: 354–62.
21 Grundy, SM, Cleeman, JI, Daniels, SR, Donato, KA, Eckel, RH, Franklin, BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735–52.
22 Forouhi, N, Balkau, B, Borch-Johnsen, K, Dekker, J, Glumer, C, Qiao, Q, et al. The threshold for diagnosing impaired fasting glucose: a position statement by the European diabetes epidemiology group. Diabetologia 2006; 49: 822–7.
23 International Expert Committee. International expert committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327–34.
24 Eisenmann, JC. On the use of a continuous metabolic syndrome score in pediatric research. Cardiovasc Diabetol 2008; 7: 1722.
25 Bakker, SJ, Gansevoort, RT, de Zeeuw, D. Metabolic syndrome: a fata morgana? Nephrol Dial Transplant 2007; 22: 1520.
26 Zorginstituut Nederland [National Health Care Institute]. Farmacotherapeutisch Kompas [Pharmacotherapeutic Compass]. Zorginstituut Nederland, 2015 (www.farmacotherapeutischkompas.nl/inleidendeteksten/i/inl%20antipsychotica.asp).
27 UpToDate. Selected Adverse Effects of Antipsychotic Medications for Schizophrenia. Wolters Kluwer, 2015 (www.uptodate.com/contents/image?imageKey=PSYCH%2F82533&topicKey=PSYCH%2F157668.source=see_link&utdPopup=true).
28 Farin, HM, Abbasi, F, Reaven, GM. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals. Am J Cardiol 2006; 98: 1053–6.
29 Fox, KA, Despres, JP, Richard, AJ, Brette, S, Deanfield, JE, IDEA Steering Committee and National Coordinators. Does abdominal obesity have a similar impact on cardiovascular disease and diabetes? A study of 91,246 ambulant patients in 27 European countries. Eur Heart J 2009; 30: 3055–63.
30 Pischon, T, Boeing, H, Hoffmann, K, Bergmann, M, Schulze, MB, Overvad, K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008; 359: 2105–20.
31 Forsberg, KA, Björkman, T, Sandman, PO, Sandlund, M. Physical health – a cluster randomized controlled lifestyle intervention among persons with a psychiatric disability and their staff. Nord J Psychiatry 2008; 62: 486–95.
32 Hjorth, P, Davidsen, AS, Kilian, R, Pilgaard Eriksen, S, Jensen, SO, S⊘rensen, , et al. Improving the physical health of long-term psychiatric inpatients. Aust NZ J Psychiatry 2014; 48: 861–70.
33 Roumen, C, Blaak, EE, Corpeleijn, E. Lifestyle intervention for prevention of diabetes: Determinants of success for future implementation. Nutr Rev 2009; 67: 132–46.
34 Goodyear, P, Laurie, J, Kahn, M, Barbara, B. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 1998; 49: 235–61.
35 McKibbin, CL, Patterson, TL, Norman, G, Patrick, K, Jin, H, Roesch, S, et al. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res 2006; 86: 3644.
36 Kaczynski, AT, Henderson, KA. Environmental correlates of physical activity: a review of evidence about parks and recreation. Leis Sci 2007; 29: 315–54.
37 Doucette, PA. Walk and talk: an intervention for behaviorally challenged youths. Adolescence 2004; 39: 373–88.
38 Lean, M, Leavey, G, Killaspy, H, Green, N, Harrison, I, Cook, S, et al. Barriers to the sustainability of an intervention designed to improve patient engagement within NHS mental health rehabilitation units: a qualitative study nested within a randomised controlled trial. BMC Psychiatry 2015; 15: 209.
39 Bradshaw, T, Wearden, A, Marshall, M, Warburton, J, Husain, N, Pedley, R, et al. Developing a healthy living intervention for people with early psychosis using the medical research council's guidelines on complex interventions: Phase 1 of the HELPER-InterACT programme. Int J Nurs Stud 2012; 49: 398406.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 80 *
Loading metrics...

Abstract views

Total abstract views: 197 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 19th June 2018. This data will be updated every 24 hours.

Changing the obesogenic environment to improve cardiometabolic health in residential patients with a severe mental illness: cluster randomised controlled trial

  • Anne Looijmans (a1), Annemarie P. M. Stiekema (a2), Richard Bruggeman (a3), Lisette van der Meer (a4) (a2), Ronald P. Stolk (a5), Robert A. Schoevers (a6), Frederike Jörg (a4) (a7) and Eva Corpeleijn (a8)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *